| 1. | Durability of hbeag seroconversion in lamivudine treatment of chronic hepatitis b patients
拉米夫定治疗慢性乙型肝炎出现血清转换的持续性研究 |
| 2. | Durability of seroconversion after long - term lamivudine therapy in hbeag positive chronic hepatitis b patients
阳性慢性乙型肝炎患者血清转换持久性的研究 |
| 3. | Objectives : to establish natural seroconversion rates and incidence of hepatic pathology in perinatally infected hepatitis b carriers
目的：为了建立围产期感染乙型肝炎的携带者发生血清学转换的比率和肝脏病理学的发生情况。 |
| 4. | Aids health project counselors tell their hiv test clients that " seroconversion is detectable in 90 % of people within three months of exposure ; the average time is 25 days .
Aids健康顾问告诉检测者： 90的人会在3个月内检测到血清转阳，平均时间是25天。 |
| 5. | The results found a 65 % decrease in hiv seroconversion in women who received tenofovir ( 0 . 86 % per 100 person - years ) compared with women who received placebo ( 2 . 48 % per 100 person - years ) , although the difference did not reach statistical significance
结果表明，使用泰诺福韦的女性， hiv血清转化率降低了65 % ，有一年0 . 86 %的人发生了转化，而使用安慰剂的女性中，一年有2 . 48 %的人发生了血清转化，尽管这个差别并没有达到具有统计意义的要求。 |
| 6. | The highly effective prevention education that was given to study participants in both arms of the study may have resulted in lower rates of seroconversion than had been anticipated ( two in the tenofovir arm and six in the placebo arm ) , decreasing the ability of the study to detect a significant difference in risk of hiv infection
对两组参与者进行的极为有效的安全教育也有可能是血清转化率低于预期效果的原因，从而降低了该研究探索泰诺福韦在预防hiv感染中和其他疗法的差别的能力。 |
